The complication rate following Neodymium-doped Yttrium Aluminum Garnet laser posterior capsulotomy for posterior capsular opacification in patients with and without comorbidities.
Intraocular lens
neodymium-doped yttrium aluminum garnet laser
phacoemulsification
posterior capsular opacification
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
8
3
2023
Statut:
ppublish
Résumé
To study the complication rate following Nd: YAG posterior capsulotomy posterior capsular opacification (PCO) in patients with and without comorbid conditions. This was a prospective, interventional, comparative, and observational study. A total of 80 eyes, consisting of 40 eyes without ocular comorbidities (group A) and 40 eyes with ocular comorbidities (group B) that were being treated with Nd: YAG capsulotomy for PCO, were included. Visual outcome and complications of Nd: YAG capsulotomy were studied. The mean age of group A patients was 61.65 ± 8.85 years and that of group B patients was 63 ± 10.46 years. Of the total, 38 (47.5%) were men and 42 (52.5%) were women. In group B, the ocular comorbidities were moderate nonproliferative diabetic retinopathy (NPDR) (n = 14 eyes; 14/40 = 35%), subluxated intraocular lens (IOL; <2 clock hours of subluxation; n = 6), age-related macular degeneration (ARMD; n = 6), post-uveitic eyes (having old signs of uveitis, no episode of uveitis since the last 1 year; n = 5), and operated cases of traumatic cataract (n = 4). The mean energy required in groups A and B was 46.95 ± 25.92 and 42.62 ± 21.85 mJ, respectively (P = 0.422). The average energy requirement in Grade 2, Grade 3, and Grade 4 PCO was 22.30, 41.62, and 79.52 mJ, respectively. An increase in intraocular pressure (IOP) of >5 mmHg from pre-YAG levels was observed in one patient in each group on day 1 postprocedure, for which medical treatment was given to both patients for 7 days. One patient in each group had IOL pitting. No patient had any other complications attributable to ND:YAG capsulotomy. Nd:YAG laser posterior capsulotomy is a safe procedure for PCO in patients with comorbidities. Visual outcomes were excellent after Nd:YAG posterior capsulotomy. Although a transient increase in IOP was noted, the response to treatment was good and a long-term increase in IOP was not observed.
Identifiants
pubmed: 36872680
pii: IndianJOphthalmol_2023_71_3_791_371067
doi: 10.4103/ijo.IJO_1885_22
pmc: PMC10229945
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
791-796Commentaires et corrections
Type : CommentIn
Type : CommentIn
Déclaration de conflit d'intérêts
None
Références
Arch Ophthalmol. 2000 Oct;118(10):1334-7
pubmed: 11030814
Nepal J Ophthalmol. 2012 Jan-Jun;4(1):108-13
pubmed: 22344007
J Cataract Refract Surg. 2001 Jul;27(7):1039-46
pubmed: 11489573
Cureus. 2021 Jul 7;13(7):e16242
pubmed: 34373805
Acta Med Croatica. 2006;60(2):109-12
pubmed: 16848199
Int Ophthalmol. 2017 Aug;37(4):1003-1008
pubmed: 27699606
Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):67-71
pubmed: 20143510
J Cataract Refract Surg. 2013 May;39(5):699-704
pubmed: 23499069
J Curr Glaucoma Pract. 2017 May-Aug;11(2):63-66
pubmed: 28924341
Ophthalmology. 1999 Jan;106(1):49-54; discussion 54-5
pubmed: 9917780
Arch Ophthalmol. 2009 Apr;127(4):555-62
pubmed: 19365040
Arq Bras Oftalmol. 2008 Sep-Oct;71(5):706-10
pubmed: 19039468
J Cataract Refract Surg. 2006 Oct;32(10):1627-31
pubmed: 17010858
J Cataract Refract Surg. 2000 Feb;26(2):180-7
pubmed: 10683785
Clin Ophthalmol. 2009;3:363-5
pubmed: 19668591
Eur J Ophthalmol. 2002 Sep-Oct;12(5):388-94
pubmed: 12474921
Am J Ophthalmol. 2012 Nov;154(5):808-813.e1
pubmed: 22958858
Ophthalmic Surg Lasers Imaging. 2012 Sep-Oct;43(5):395-400
pubmed: 22785102
Indian J Ophthalmol. 2004 Jun;52(2):99-112
pubmed: 15283214
BMC Ophthalmol. 2019 Feb 4;19(1):40
pubmed: 30717688
Indian J Ophthalmol. 2017 Dec;65(12):1440-1444
pubmed: 29208831
Arch Soc Esp Oftalmol. 2013 Nov;88(11):415-22
pubmed: 24157319
Eye (Lond). 1999 Jun;13 ( Pt 3b):489-92
pubmed: 10627830
Ophthalmology. 1985 Jul;92(7):973-6
pubmed: 4022582
J Ophthalmic Vis Res. 2015 Jan-Mar;10(1):37-42
pubmed: 26005551
Surv Ophthalmol. 1992 Sep-Oct;37(2):73-116
pubmed: 1455302
Indian J Ophthalmol. 2019 Sep;67(9):1428-1432
pubmed: 31436186
Med Hypothesis Discov Innov Ophthalmol. 2014 Summer;3(2):45-50
pubmed: 25738159